Add Yahoo as a preferred source to see more of our stories on Google. Around 125 million people worldwide have psoriasis, the skin condition that causes flaky patches on the surface to form as scales.

Did you know that more than 7 million people in the U.S. have psoriasis? It may not be as well known or talked about as other skin conditions like eczema or rosacea, but it's something that a lot of ...

Finding a cream that actually helps with psoriasis can make a real difference. Whether your skin is inflamed, sensitive, or just uncomfortable, the right skincare product can calm irritation and leave ...

People with psoriasis have to be especially thoughtful about the skin care products they use, so when shopping for the best moisturizers for face psoriasis, look for ones that contain natural ...

Please provide your email address to receive an email when new articles are posted on . Arcutis Biotherapeutics announced positive results from two pivotal phase 3 studies evaluating Zoryve cream as a ...

HUNTINGTON BEACH, Calif. — The US Food and Drug Administration (FDA) approvals of tapinarof 1% cream and roflumilast 0.3% cream as treatment options for patients with plaque psoriasis came more than 1 ...

Hot off its first approval this summer in psoriasis, Arcutis Biotherapeutics’ roflumilast foam 0.3%, approved in cream form under the brand name Zoryve, is out to prove it’s no one-trick pony in itch.

A PDUFA target date of June 29, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for roflumilast cream 0.3% for ...

Arcutis Biotherapeutics has spent the weeks since the FDA approval of its topical plaque psoriasis cream Zoryve strengthening its cash position, drawing down $125 million from its loan facility and ...

The FDA has approved the first topical novel therapy for psoriasis in 25 years, Roivant Sciences announced. Tapinarof cream 1% (Vtama) received an indication for mild, moderate, and severe plaque ...

Please provide your email address to receive an email when new articles are posted on . Dermavant Sciences partner, Japan Tobacco, received approval for Vtama cream 1% in Japan. Approved indications ...

- 88.5% of adult patients achieved a target lesion Physician Global Assessment (tPGA) score of 0 (clear) or 1 (almost clear) and ≥ 2-grade improvement from baseline at Week 12 (tPGA Success), ...